To view this email as a web page, click here.
 
 
Oncologists Responsive to FDA Label Restrictions
After the FDA restricted the labels of 2 drugs used to treat bladder cancer, oncologists' use of these treatments decreased drastically.
Read more
 
 
What Percentage of Cancer Diagnoses Are Made in the Emergency Department?
Some patients are more likely to find out about their cancer via a visit to the emergency department than others.
Read more
 
 
IN CASE YOU MISSED IT
 
FDA Expands Indicated Age Range for CRC Screening Tool
As more younger adults are diagnosed with colorectal cancer, the FDA approved Cologuard, a stool-based, at-home colorectal cancer screening, for adults aged 45 to 49 years.
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.